News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,463 Results
Type
Article (81331)
Company Profile (722)
Press Release (784387)
Multimedia
Podcasts (238)
Webinars (35)
Section
Business (231006)
Career Advice (3994)
Deals (39704)
Drug Delivery (178)
Drug Development (90550)
Employer Resources (207)
FDA (18377)
Job Trends (17343)
News (393862)
Policy (39451)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (41)
Allergies (207)
Alliances (56580)
ALS (236)
Alzheimer's disease (1977)
Antibody-drug conjugate (ADC) (559)
Approvals (18729)
Artificial intelligence (846)
ASCO (344)
Autoimmune disease (362)
Automation (65)
Bankruptcy (404)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (249)
Biotechnology (442)
Bladder cancer (210)
Brain cancer (85)
Breast cancer (837)
Cancer (6604)
Cardiovascular disease (558)
Career advice (3446)
Career pathing (52)
CAR-T (387)
CDC (76)
Celiac Disease (3)
Cell therapy (1063)
Cervical cancer (55)
Clinical research (78198)
Collaboration (2391)
Commercialization (1)
Company closure (8)
Compensation (1529)
Complete response letters (106)
COVID-19 (3042)
CRISPR (125)
C-suite (1300)
Cystic fibrosis (167)
Data (8778)
Decentralized trials (3)
Denatured (90)
Depression (197)
Dermatology (97)
Diabetes (711)
Diagnostics (7600)
Digital health (70)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (412)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (101178)
Editorial (79)
Employer branding (25)
Employer resources (174)
Events (138099)
Executive appointments (1200)
FDA (22469)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1954)
Gene editing (273)
Generative AI (83)
Gene therapy (850)
GLP-1 (1287)
Government (5541)
Grass and pollen (8)
Guidances (420)
Healthcare (21256)
Hematology (197)
HIV (96)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (355)
Immuno-oncology (116)
Indications (212)
Infectious disease (3442)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (149)
Intellectual property (322)
Interviews (787)
IPO (17958)
IRA (61)
Job creations (5062)
Job search strategy (2755)
JPM (73)
Kidney cancer (23)
Labor market (123)
Layoffs (689)
Leadership (53)
Legal (10083)
Liver cancer (111)
Longevity (36)
Lung cancer (875)
Lymphoma (480)
Machine learning (67)
Management (66)
Manufacturing (1229)
Marketing (1)
MASH (227)
Medical affairs (1)
Medical device (15265)
Medtech (15432)
Mergers & acquisitions (23060)
Metabolic disorders (1836)
mRNA (271)
Multiple sclerosis (205)
NASH (24)
Neurodegenerative disease (512)
Neuropsychiatric disorders (130)
Neuroscience (3737)
Neurotech (1)
NextGen: Class of 2026 (7683)
Non-profit (5146)
Now hiring (82)
Obesity (874)
Opinion (375)
Ovarian cancer (244)
Pain (285)
Pancreatic cancer (360)
Parkinson's disease (418)
Partnered (39)
Patents (659)
Patient recruitment (770)
Peanut (71)
People (67334)
Pharmaceutical (127)
Pharmacy benefit managers (38)
Phase 1 (24195)
Phase 2 (34076)
Phase 3 (25629)
Pipeline (9899)
Policy (398)
Postmarket research (3356)
Preclinical (10744)
Press Release (72)
Prostate cancer (350)
Psychedelics (71)
Radiopharmaceuticals (373)
Rare diseases (1277)
Real estate (7309)
Recruiting (81)
Regulatory (29987)
Reports (77)
Research institute (2769)
Resumes & cover letters (631)
Rett syndrome (43)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (332)
Series B (240)
Service/supplier (26)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4346)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (145)
Vaccines (1312)
Venture capital (136)
Weight loss (599)
Women's health (141)
Worklife (24)
Date
Today (118)
Last 7 days (509)
Last 30 days (2894)
Last 365 days (32853)
2026 (16586)
2025 (32713)
2024 (37922)
2023 (42563)
2022 (53928)
2021 (58719)
2020 (57662)
2019 (51319)
2018 (39103)
2017 (36999)
2016 (38036)
2015 (44093)
2014 (38981)
2013 (35311)
2012 (37265)
2011 (37285)
2010 (37199)
Location
Africa (1254)
Alabama (102)
Alaska (7)
Arizona (391)
Arkansas (16)
Asia (51300)
Australia (8835)
California (14437)
Canada (4018)
China (1587)
Colorado (622)
Connecticut (641)
Delaware (447)
Europe (117633)
Florida (2152)
Georgia (469)
Hawaii (4)
Idaho (70)
Illinois (1243)
India (104)
Indiana (666)
Iowa (26)
Japan (604)
Kansas (143)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1748)
Massachusetts (10578)
Michigan (420)
Minnesota (805)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3832)
New Mexico (35)
New York (3798)
North Carolina (1936)
North Dakota (11)
Northern California (7191)
Ohio (449)
Oklahoma (27)
Oregon (53)
Pennsylvania (2837)
Puerto Rico (33)
Rhode Island (55)
South America (1624)
South Carolina (88)
South Dakota (2)
Southern California (5672)
Tennessee (232)
Texas (2337)
United States (51621)
Utah (430)
Vermont (1)
Virginia (372)
Washington D.C. (89)
Washington State (1185)
West Virginia (4)
Wisconsin (158)
Wyoming (2)
866,463 Results for "biotronik se and co kg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
June 2, 2026
·
6 min read
Press Releases
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026
May 17, 2026
·
4 min read
Press Releases
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
June 3, 2026
·
6 min read
Press Releases
Evotec SE to Announce First Quarter 2026 Results on May 6, 2026
April 29, 2026
·
3 min read
Press Releases
AAHI’s SLA-SE Adjuvant Technology Powers Lilly’s Acquisition of Curevo’s Next-Generation Shingles Vaccine
May 28, 2026
·
1 min read
Press Releases
Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
April 1, 2026
·
3 min read
Press Releases
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
March 31, 2026
·
8 min read
Press Releases
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
February 2, 2026
·
9 min read
Press Releases
EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis
March 31, 2026
·
3 min read
Press Releases
Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
February 17, 2026
·
6 min read
1 of 86,647
Next
